Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ensley

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cancer|January 15, 1987
Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancerK Al-Kourainy, J Kish, J Ensley, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2000
The influence of beam energy on the outcome of postoperative radiotherapy in head and neck cancer patients: secondary analysis of RTOG 85-03A Aref, B A Berkey, J G Schwade, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1989
Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective studyS Rezkalla, R A Kloner, J Ensley, et al.
Investigational New Drugs|January 1, 1994
Phase II study of edatrexate in advanced head and neck cancer. A Southwest Oncology Group studyJ P Kuebler, J Benedetti, D E Schuller, et al.
Cancer Research|December 15, 1996
Mutations in the arginine-rich protein gene, in lung, breast, and prostate cancers, and in squamous cell carcinoma of the head and neckR Shridhar, V Shridhar, S Rivard, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 11, 1999
Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with head and neck squamous cell carcinomaT Y Shibuya, W Z Wei, M Zormeier, et al.
Archives of Otolaryngology--Head & Neck Surgery|April 20, 2000
Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinomaT Y Shibuya, W Z Wei, M Zormeier, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cancer|January 15, 1987
Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancerK Al-Kourainy, J Kish, J Ensley, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2000
The influence of beam energy on the outcome of postoperative radiotherapy in head and neck cancer patients: secondary analysis of RTOG 85-03A Aref, B A Berkey, J G Schwade, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1989
Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective studyS Rezkalla, R A Kloner, J Ensley, et al.
Investigational New Drugs|January 1, 1994
Phase II study of edatrexate in advanced head and neck cancer. A Southwest Oncology Group studyJ P Kuebler, J Benedetti, D E Schuller, et al.
Cancer Research|December 15, 1996
Mutations in the arginine-rich protein gene, in lung, breast, and prostate cancers, and in squamous cell carcinoma of the head and neckR Shridhar, V Shridhar, S Rivard, et al.
Archives of Otolaryngology--Head & Neck Surgery|November 11, 1999
Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with head and neck squamous cell carcinomaT Y Shibuya, W Z Wei, M Zormeier, et al.
Archives of Otolaryngology--Head & Neck Surgery|April 20, 2000
Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinomaT Y Shibuya, W Z Wei, M Zormeier, et al.
Pageof 3